Your browser doesn't support javascript.
loading
Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity.
Iwamura, Chiaki; Hirahara, Kiyoshi; Kiuchi, Masahiro; Ikehara, Sanae; Azuma, Kazuhiko; Shimada, Tadanaga; Kuriyama, Sachiko; Ohki, Syota; Yamamoto, Emiri; Inaba, Yosuke; Shiko, Yuki; Aoki, Ami; Kokubo, Kota; Hirasawa, Rui; Hishiya, Takahisa; Tsuji, Kaori; Nagaoka, Tetsutaro; Ishikawa, Satoru; Kojima, Akira; Mito, Haruki; Hase, Ryota; Kasahara, Yasunori; Kuriyama, Naohide; Tsukamoto, Tetsuya; Nakamura, Sukeyuki; Urushibara, Takashi; Kaneda, Satoru; Sakao, Seiichiro; Tobiume, Minoru; Suzuki, Yoshio; Tsujiwaki, Mitsuhiro; Kubo, Terufumi; Hasegawa, Tadashi; Nakase, Hiroshi; Nishida, Osamu; Takahashi, Kazuhisa; Baba, Komei; Iizumi, Yoko; Okazaki, Toshiya; Kimura, Motoko Y; Yoshino, Ichiro; Igari, Hidetoshi; Nakajima, Hiroshi; Suzuki, Takuji; Hanaoka, Hideki; Nakada, Taka-Aki; Ikehara, Yuzuru; Yokote, Koutaro; Nakayama, Toshinori.
Afiliação
  • Iwamura C; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Hirahara K; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Kiuchi M; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Ikehara S; Department of Pathology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Azuma K; Department of Pathology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Shimada T; Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Kuriyama S; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Ohki S; Department of Pathology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Yamamoto E; Department of Pathology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Inaba Y; Clinical Research Center, Chiba University Hospital, Chiba 260-8677, Japan.
  • Shiko Y; Clinical Research Center, Chiba University Hospital, Chiba 260-8677, Japan.
  • Aoki A; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Kokubo K; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Hirasawa R; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Hishiya T; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Tsuji K; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Nagaoka T; Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo 113-8431, Japan.
  • Ishikawa S; Department of Respiratory Medicine, Funabashi Central Hospital, Chiba 273-8556, Japan.
  • Kojima A; Department of Respiratory Medicine, Funabashi Central Hospital, Chiba 273-8556, Japan.
  • Mito H; Department of Infectious Diseases, Japanese Red Cross Narita Hospital, Chiba 286-0041, Japan.
  • Hase R; Department of Infectious Diseases, Japanese Red Cross Narita Hospital, Chiba 286-0041, Japan.
  • Kasahara Y; Department of Respiratory Medicine, Eastern Chiba Medical Center, Chiba 283-8686, Japan.
  • Kuriyama N; Department of Anesthesiology and Critical Care Medicine, School of Medicine, Fujita Health University, Aichi 470-1192, Japan.
  • Tsukamoto T; Department of Pathology, School of Medicine, Fujita Health University, Aichi 470-1192, Japan.
  • Nakamura S; Department of Respirology, Funabashi Municipal Medical CenterChiba 273-8588, Japan.
  • Urushibara T; Department of Respirology, Kimitsu Chuo Hospital, Chiba 292-0822, Japan.
  • Kaneda S; Department of Gastroenterology, National Hospital Organization Chiba Medical Center, Chiba 260-8606, Japan.
  • Sakao S; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Tobiume M; Department of Pathology, Asahi General Hospital, Chiba 289-2511, Japan.
  • Suzuki Y; Department of Pathology, Asahi General Hospital, Chiba 289-2511, Japan.
  • Tsujiwaki M; Department of Surgical Pathology, Sapporo Medical University of Medicine, Sapporo 060-8543, Japan.
  • Kubo T; Department of Surgical Pathology, Sapporo Medical University of Medicine, Sapporo 060-8543, Japan.
  • Hasegawa T; Department of Surgical Pathology, Sapporo Medical University of Medicine, Sapporo 060-8543, Japan.
  • Nakase H; Department of Gastroenterology and Hepatology, Sapporo Medical University of Medicine, Sapporo 060-8543, Japan.
  • Nishida O; Department of Anesthesiology and Critical Care Medicine, School of Medicine, Fujita Health University, Aichi 470-1192, Japan.
  • Takahashi K; Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo 113-8431, Japan.
  • Baba K; DLC Research Institute LLC, Nagasaki 850-0011, Japan.
  • Iizumi Y; CNT-Application Research Center, National Institute of Advanced Industrial Science and Technology, Tsukuba 305-8565, Japan.
  • Okazaki T; CNT-Application Research Center, National Institute of Advanced Industrial Science and Technology, Tsukuba 305-8565, Japan.
  • Kimura MY; Department of Experimental Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Yoshino I; Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Igari H; Department of Infectious Diseases, Chiba University Hospital, Chiba 260-8677, Japan.
  • Nakajima H; COVID-19 Vaccine Center, Chiba University Hospital, Chiba 260-8677, Japan.
  • Suzuki T; COVID-19 Vaccine Center, Chiba University Hospital, Chiba 260-8677, Japan.
  • Hanaoka H; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Nakada TA; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Ikehara Y; Clinical Research Center, Chiba University Hospital, Chiba 260-8677, Japan.
  • Yokote K; Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Nakayama T; Department of Pathology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Proc Natl Acad Sci U S A ; 119(33): e2203437119, 2022 08 16.
Article em En | MEDLINE | ID: mdl-35895716
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasculite / Índice de Gravidade de Doença / Cadeias Leves de Miosina / SARS-CoV-2 / COVID-19 / Tromboinflamação / Pulmão Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasculite / Índice de Gravidade de Doença / Cadeias Leves de Miosina / SARS-CoV-2 / COVID-19 / Tromboinflamação / Pulmão Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão